Clinical trial
The University of Ottawa Dapagliflozin in STEMI Randomized Clinical Trial
NCT06174753 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The University of Ottawa Dapagliflozin in STEMI Randomized Clinical Trial
- Lead sponsor
- Ottawa Heart Institute Research Corporation
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- January 20, 2025
- Completion date
- December 31, 2027
- Enrollment
- 256 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.